Majumder et al. [13] found that variant genotype (Asn/Asn) at codon 312 of XPD is associated with increased risk of cancer among rapid and intermediate acetylators (OR = 1.9, 95% CI = 1.2–2.9). This evidence concerns the gene ERCC2 and cancer.